Life Sciences

Could a New Eye Drop Make Reading Glasses Obsolete?
Care Could a New Eye Drop Make Reading Glasses Obsolete?

The Dawn of a New Era in Vision Correction For millions of adults, the simple act of reading a menu, a text message, or a book eventually becomes a challenge. This creeping blurriness, known as presbyopia, has long been an accepted, if inconvenient, part of aging, sending a steady stream of people

Is the Era of the Biopharma Mega-Factory Over?
Care Is the Era of the Biopharma Mega-Factory Over?

The life-saving biologic drug in a hospital patient's IV drip likely began its journey years ago in a single, colossal factory thousands of miles away, a fact that represents both a triumph of modern science and a critical vulnerability. For decades, the biopharmaceutical industry has relied

Epidarex Secures $145M for Early-Stage Life Sciences
Care Epidarex Secures $145M for Early-Stage Life Sciences

The journey from a groundbreaking scientific discovery in a university laboratory to a life-saving medicine on a pharmacy shelf is one of the most challenging and capital-intensive paths in any industry. With its recent first close of over $145 million for its fourth fund, transatlantic venture

Is One HPV Vaccine Dose Enough to Prevent Cancer?
Care Is One HPV Vaccine Dose Enough to Prevent Cancer?

A fundamental pillar of modern cancer prevention is on the verge of a significant transformation, as top public health officials re-examine whether the long-standing multi-dose Human Papillomavirus (HPV) vaccine schedule could be simplified to a single shot. This review, driven by compelling new

Roche's New Drug Challenges Obesity Market Leaders
Care Roche's New Drug Challenges Obesity Market Leaders

The pharmaceutical landscape for weight management is undergoing a seismic shift, with a few key players dominating a market valued in the tens of billions, and a new entrant from Roche is poised to disrupt the established order with its promising drug candidate, CT-388. Preliminary data from its

FDA Updates Dosing Guidance for Inhaled Insulin Afrezza
Public Policy FDA Updates Dosing Guidance for Inhaled Insulin Afrezza

Transitioning from one form of insulin therapy to another has often presented a delicate balancing act, requiring careful calibration to maintain glycemic stability. For adults with diabetes considering a needle-free option, the initial dosing has been a critical hurdle. Now, a landmark revision to

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later